Abstract: Cancer; Magnetic hyperthermia; Nanoparticles Cáncer; Hipertermia magnética; Nanopartículas Càncer; Hipertèrmia magnètica; Nanopartícules The clinical implementation of magnetic hyperthermia has experienced little progress since the first clinical trial was completed in 2005. Some of the hurdles to overcome are the reliable production of magnetic nanoparticles with controlled properties and the control of the temperature at the target tissue in vivo. Here, forty samples of iron oxide superparamagnetic nanoparticles were prepared by simila...
(read more)
Topics: 
Nanotechnology
Biomedical engineering